Predictive factors for rebleeding in patients with peptic ulcer bleeding after multipolar electrocoagulation: A retrospective analysis

Hwai Jeng Lin, Guan Ying Tseng, Wen Ching Lo, Fa Yauh Lee, Chin Lin Perng, Full Young Chang, Shou Dong Lee

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The role of endoscopic therapy for peptic ulcer bleeding is well- documented. Nevertheless, rebleeding occurs in 10% to 30% of patients, and such patients are at high risk for death without early retreatment or definitive surgery. The aim of our study was to predict which patients would rebleed within 1 month after successful multipolar electrocoagulation of 100 patients with active peptic ulcer bleeding (spurting, oozing, or nonbleeding visible vessel). We had achieved initial hemostasis in 97 patients and carried out univariate and multivariate analyses to predict which patients would rebleed. Rebleeding occurred within I month in 17 (17.5%) patients. We correlated 20 clinical and endoscopic factors with rebleeding episodes. With univariate analysis, blood transfusion of 500 ml or more at entry (p <0.0001) and use of cimetidine (p = 0.01) were statistically significant for rebleeding. With multivariate analysis, use of omeprazole was an independent factor for preventing rebleeding (odds ratio, 7.68; 95% confidence interval, 1.642-35.929). We suggest that omeprazole may help to prevent rebleeding in patients who have had hemostasis with multipolar electrocoagulation.

Original languageEnglish
Pages (from-to)113-116
Number of pages4
JournalJournal of Clinical Gastroenterology
Volume26
Issue number2
DOIs
Publication statusPublished - Mar 1998
Externally publishedYes

Fingerprint

Electrocoagulation
Peptic Ulcer
Hemorrhage
Omeprazole
Hemostasis
Multivariate Analysis
Retreatment
Cimetidine
Blood Transfusion
Odds Ratio
Confidence Intervals

Keywords

  • Electrocoagulation
  • Hemostasis
  • Peptic ulcer

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Predictive factors for rebleeding in patients with peptic ulcer bleeding after multipolar electrocoagulation : A retrospective analysis. / Lin, Hwai Jeng; Tseng, Guan Ying; Lo, Wen Ching; Lee, Fa Yauh; Perng, Chin Lin; Chang, Full Young; Lee, Shou Dong.

In: Journal of Clinical Gastroenterology, Vol. 26, No. 2, 03.1998, p. 113-116.

Research output: Contribution to journalArticle

Lin, Hwai Jeng ; Tseng, Guan Ying ; Lo, Wen Ching ; Lee, Fa Yauh ; Perng, Chin Lin ; Chang, Full Young ; Lee, Shou Dong. / Predictive factors for rebleeding in patients with peptic ulcer bleeding after multipolar electrocoagulation : A retrospective analysis. In: Journal of Clinical Gastroenterology. 1998 ; Vol. 26, No. 2. pp. 113-116.
@article{524a9a3286d34890b8b5de867181f947,
title = "Predictive factors for rebleeding in patients with peptic ulcer bleeding after multipolar electrocoagulation: A retrospective analysis",
abstract = "The role of endoscopic therapy for peptic ulcer bleeding is well- documented. Nevertheless, rebleeding occurs in 10{\%} to 30{\%} of patients, and such patients are at high risk for death without early retreatment or definitive surgery. The aim of our study was to predict which patients would rebleed within 1 month after successful multipolar electrocoagulation of 100 patients with active peptic ulcer bleeding (spurting, oozing, or nonbleeding visible vessel). We had achieved initial hemostasis in 97 patients and carried out univariate and multivariate analyses to predict which patients would rebleed. Rebleeding occurred within I month in 17 (17.5{\%}) patients. We correlated 20 clinical and endoscopic factors with rebleeding episodes. With univariate analysis, blood transfusion of 500 ml or more at entry (p <0.0001) and use of cimetidine (p = 0.01) were statistically significant for rebleeding. With multivariate analysis, use of omeprazole was an independent factor for preventing rebleeding (odds ratio, 7.68; 95{\%} confidence interval, 1.642-35.929). We suggest that omeprazole may help to prevent rebleeding in patients who have had hemostasis with multipolar electrocoagulation.",
keywords = "Electrocoagulation, Hemostasis, Peptic ulcer",
author = "Lin, {Hwai Jeng} and Tseng, {Guan Ying} and Lo, {Wen Ching} and Lee, {Fa Yauh} and Perng, {Chin Lin} and Chang, {Full Young} and Lee, {Shou Dong}",
year = "1998",
month = "3",
doi = "10.1097/00004836-199803000-00005",
language = "English",
volume = "26",
pages = "113--116",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Predictive factors for rebleeding in patients with peptic ulcer bleeding after multipolar electrocoagulation

T2 - A retrospective analysis

AU - Lin, Hwai Jeng

AU - Tseng, Guan Ying

AU - Lo, Wen Ching

AU - Lee, Fa Yauh

AU - Perng, Chin Lin

AU - Chang, Full Young

AU - Lee, Shou Dong

PY - 1998/3

Y1 - 1998/3

N2 - The role of endoscopic therapy for peptic ulcer bleeding is well- documented. Nevertheless, rebleeding occurs in 10% to 30% of patients, and such patients are at high risk for death without early retreatment or definitive surgery. The aim of our study was to predict which patients would rebleed within 1 month after successful multipolar electrocoagulation of 100 patients with active peptic ulcer bleeding (spurting, oozing, or nonbleeding visible vessel). We had achieved initial hemostasis in 97 patients and carried out univariate and multivariate analyses to predict which patients would rebleed. Rebleeding occurred within I month in 17 (17.5%) patients. We correlated 20 clinical and endoscopic factors with rebleeding episodes. With univariate analysis, blood transfusion of 500 ml or more at entry (p <0.0001) and use of cimetidine (p = 0.01) were statistically significant for rebleeding. With multivariate analysis, use of omeprazole was an independent factor for preventing rebleeding (odds ratio, 7.68; 95% confidence interval, 1.642-35.929). We suggest that omeprazole may help to prevent rebleeding in patients who have had hemostasis with multipolar electrocoagulation.

AB - The role of endoscopic therapy for peptic ulcer bleeding is well- documented. Nevertheless, rebleeding occurs in 10% to 30% of patients, and such patients are at high risk for death without early retreatment or definitive surgery. The aim of our study was to predict which patients would rebleed within 1 month after successful multipolar electrocoagulation of 100 patients with active peptic ulcer bleeding (spurting, oozing, or nonbleeding visible vessel). We had achieved initial hemostasis in 97 patients and carried out univariate and multivariate analyses to predict which patients would rebleed. Rebleeding occurred within I month in 17 (17.5%) patients. We correlated 20 clinical and endoscopic factors with rebleeding episodes. With univariate analysis, blood transfusion of 500 ml or more at entry (p <0.0001) and use of cimetidine (p = 0.01) were statistically significant for rebleeding. With multivariate analysis, use of omeprazole was an independent factor for preventing rebleeding (odds ratio, 7.68; 95% confidence interval, 1.642-35.929). We suggest that omeprazole may help to prevent rebleeding in patients who have had hemostasis with multipolar electrocoagulation.

KW - Electrocoagulation

KW - Hemostasis

KW - Peptic ulcer

UR - http://www.scopus.com/inward/record.url?scp=0031898396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031898396&partnerID=8YFLogxK

U2 - 10.1097/00004836-199803000-00005

DO - 10.1097/00004836-199803000-00005

M3 - Article

C2 - 9563921

AN - SCOPUS:0031898396

VL - 26

SP - 113

EP - 116

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 2

ER -